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Magnetic resonance imaging (MRI) with diffusion weight-ing (DWI-MRI) detects more ischemic stroke lesions than 
computed tomography1 and is recommended to diagnose stroke 
in national stroke guidelines.2 There is an increasing reluctance 
to diagnose stroke in patients who have clinical features of stroke 
and a negative DWI. Previous studies found that DWI-MRI did 
not identify a relevant ischemic lesion in one third of patients 
with a nondisabling stroke,3,4 but there is little information on 
these patients’ long-term prognosis. If patients without a DWI-
MRI lesion (DWI-negative) have not had a stroke, then we would 
expect that they would have a better prognosis with a lower risk of 
long-term dependency, recurrent stroke, and cognitive impairment 
than patients with a DWI-visible ischemic lesion (DWI-positive).
Objectives
We aimed to determine (1) the proportion of patients with non-
disabling stroke without an acute ischemic lesion on DWI-MRI, 
(2) whether these patients are clinically different at presentation 
from those with a lesion, and (3) whether they have a reduced 
risk of recurrent stroke, ongoing significant symptoms, depen-
dency, or cognitive impairment at 1 year. We also updated a 
systematic review and meta-analysis of all recent studies.
Methods
Study Population and Recruitment
We performed a prospective observational study, recruiting consecu-
tive inpatients and outpatients with mild (ie, nondisabling) ischemic 
stroke who presented to the Lothian regional stroke service from May 
2010 to May 2012. We defined a nondisabling ischemic stroke as fo-
cal onset of neurological symptoms lasting >24 hours, with no other 
explanation, which did not cause significant impairment in basic ac-
tivities of daily living at presentation.
We excluded patients who did not have a diagnosis of stroke, 
those whose symptoms resolved within 24 hours, those who were un-
able to consent (eg, because of dementia or aphasia), those who had 
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a contraindication to MRI, those with clearly disabling stroke, and 
those with another medical condition, which meant that they were 
unlikely to survive for a year.
All participants involved in the study gave written informed con-
sent, and the study was approved by the Lothian Research Ethics 
committee (ref 09/S1101/54).
Collection of Clinical Data
The clinical research fellow (S.D.J.M.) assessed all patients and re-
corded clinical features, baseline demographics, and risk factors 
(Table 1). We classified the stroke subtype using the Oxfordshire 
Community Stroke Project classification.5 We determined whether 
symptoms were likely to relate to anterior or posterior circulation and 
recorded whether the patient had previous stroke or transient ischemic 
attack (TIA), ischemic heart disease, atrial fibrillation, hypertension 
(defined as blood pressure of ≥140/90 mm Hg on presentation or a pre-
vious diagnosis), hyperlipidemia (cholesterol >5 mmol/L on presenta-
tion or a previous diagnosis), previous diagnosis or current symptoms 
of peripheral vascular disease, diabetes mellitus (previous diagno-
sis or diagnosed on admission in accordance with the World Health 
Organization criteria), family history of stroke, and smoking status. 
We recorded the worst National Institutes of Health Stroke Scale 
score; if symptoms had improved before the assessment, we estimated 
the score at the worst point from the history and referral information.
Imaging
All patients underwent a brain MRI scan on the same 1.5 Tesla MRI 
scanner (Signa LX; General Electric, Milwaukee, WI) operating in 
research mode, and using a self-shielding gradient set with maxi-
mum strength of 33 mT/m, and an 8-channel phased-array head coil. 
The scanner was operated within a tight quality assurance program 
to maintain uniform performance. Sequences included axial DWI 
(30-direction axial diffusion tensor imaging, b=1000 s/mm2 and 
2×b0 acquisitions, repetition time/echo time [TR/TE]=7700/82 ms, 
24×24 cm field of view [FoV], 128×128 acquisition matrix, 28×5-
mm slices), T2-weighted (TR/TE=6000/90 ms, 24×24 cm FoV, 
384×384 propeller acquisition, 1.5 averages), axial fluid-attenuated 
inversion recovery (TR/TE/inversion time =9000/153/2200, 24×24 
cm FoV, 384 (anterior-posterior)×224 acquisition matrix), T2* (TR/
TE=800/15 ms, 20° flip angle, 24 (anterior-posterior)×18 cm FoV, 
384×168 acquisition matrix, 2 averages, all with 28×5-mm slices 
and 1-mm slice gap), and sagittal 3D T1-weighted (TR/TE/inversion 
time=7.3/2.9/500 ms, 8° flip angle, 330 (superior-inferior)×214.5 cm 
FoV, 256×146 acquisition matrix, 100×1.8-mm slices). An ECG and 
routine blood tests (including serum glucose, lipids, erythrocyte sedi-
mentation rate, and renal and liver function tests) were performed. 
Patients had carotid Doppler ultrasound imaging to identify carotid 
stenosis, defining symptomatic carotid stenosis as >50% stenosis 
on the relevant side measured by the North American Symptomatic 
Carotid Endarterectomy Trial criteria.6 Echocardiography and 
Table 1. Comparison of Patients With and Without a Lesion on Magnetic Resonance Imaging
Patients With a Lesion  
at Index Stroke (n=188)
Patients Without a Lesion 
Index Stroke (n=76) P Value
OR on Multivariable 
Analysis
Median age, y (IQR) 67 (60–76) 66 (57–75) 0.38 1.00 (0.98–1.03)
Male sex 117 (62%) 37 (49%) 0.053 2.09 (1.13–3.93)*
Diabetes mellitus 22 (12%) 8 (11%) 1.00 …
Hypertension 99 (53%) 42 (54%) 1.00 …
Hyperlipidemia 114 (61%) 47 (62%) 0.89 …
Smoker in last 12 mo 75 (40%) 27 (36%) 0.58 …
Atrial fibrillation 21 (11%) 4 (5%) 0.16 …
Carotid stenosis (n=235) (either side) 25/169 (15%) 2/66 (3%) 0.012 …
Stroke symptoms present at time of MRI 148 (78%) 49 (66%) 0.06 …
Symptomatic carotid stenosis 15 (9%) 2 (3%) 0.17 …
Potential embolic source (AF or symptomatic carotid stenosis) 35 (20%) 6 (9%) 0.039 2.47 (0.98–7.24)
Ischemic heart disease 31 (16) 22 (29) 0.027 …
Peripheral vascular disease 12 (6%) 3 (4%) 0.57 …
Previous transient ischemic attack 14 (7%) 14 (18%) 0.014 …
Previous stroke 16 (9%) 16 (21%) 0.0068
Previous stroke or TIA 0.23 (0.11–0.46) *
  Previous large-vessel disease 57 (30%) 23 (30%) 0.88 …
  Median white matter lesions on index stroke Fazekas scale (IQR) 3 (2–5) 2 (2–4) 0.015 …
  Posterior circulation symptoms 42 (22%) 18 (24%) 0.74 …
Median days from onset of symptoms: scan (IQR) 4 (2–9) 6 (3–11) 0.026 1.00 (0.985–1.01)
  Symptoms of lacunar stroke 78 (41%) 41 (54%) 0.039 …
  Median NIHSS (IQR) 2 (1.25–4) 2 (1–2) 0.03 …
  Stroke in follow-up 16 (9%) 8 (11%) 0.64 …
  TIA in follow-up 3 (2%) 3 (4%) 0.34 …
  Either stroke or TIA in follow-up 19 (10%) 11 (14%) 0.39 …
  modified Rankin Scale score ≥2 86 (46%) 32 (42%) 0.68 …
  Cognitive impairment at 1 y (n=151) 37 (33%) 19 (48%) 0.13 …
AF indicates atrial fibrillation; IQR, interquartile range; MRI, magnetic resonance imaging; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; and TIA, 
transient ischemic attack.
*P<0.05.
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other investigations were performed according to clinical practice 
guidelines.2
Diagnosis
A panel of neurologists, stroke physicians, and neuroradiologists 
met weekly to discuss the clinical findings, MRI images, all other 
investigations and to reach a final consensus diagnosis. We included a 
patient if the final diagnosis was of ischemic stroke defined as a sud-
den onset of neurological symptoms, lasting >24 hours, with no other 
more likely causes identified.
An experienced neuroradiologist (J.M.W.) assessed all scans for 
acute ischemic lesions, according to well-defined criteria for identi-
fying ischemic lesions on neuroimaging.7 We classed a lesion as rel-
evant to the presenting symptoms if it was of the appropriate size and 
shape for an infarct, in the appropriate brain location, and appeared of 
the right age to have caused the stroke symptoms. We defined lacunar 
infarct as a lesion <20-mm axial diameter in the deep gray or white 
matter of the cerebral hemispheres or brain stem. We defined cortical 
infarct as a lesion involving cortex or a large subcortical infarct >20-
mm axial diameter (striatocapsular). We rated white matter hyperin-
tensities (WMH) on the Fazekas scale8 and summed the peripheral 
and deep WMH scores to create a Total Fazekas score.
Follow-Up
We followed up all participants at 1 year after the stroke, with face-to-face 
assessment, review of hospital records, and a repeat MRI. If a participant 
could not attend a follow-up appointment, we performed a telephone in-
terview or sent a postal questionnaire. If we could not contact patients 
or their carers, we obtained information from their general practitioners.
At 1 year, we recorded whether a recurrent stroke, TIA, or other 
vascular event had been diagnosed formally or whether the partici-
pant had any new symptoms suggestive of recurrent stroke or TIA. 
We also established whether there had been further clinical events 
that called the original diagnosis of stroke into question, eg, recurrent 
stereotyped events that may indicate migraine. We rated disability us-
ing the structured interview version of the modified Rankin Scale9 
and assessed cognitive function using the Addenbrooke Cognitive 
Assessment Revised.10 We defined a participant as symptomatic of the 
index stroke if they were still experiencing symptoms, which had led 
to a change in their lifestyle (modified Rankin Scale score, >1). We 
defined cognitive impairment as Addenbrooke Cognitive Assessment 
Revised <88, which is recognized to be consistent with dementia.10
All 1-year MRI scans were read by an experienced neuroradiologist 
(J.M.W.) to identify any new lesions. The scan rating was performed 
blind to clinical follow-up details, first blind to and then comparing 
the follow-up with the presentation MRI and noting the location of 
any new ischemic or hemorrhagic lesions. The location of any new le-
sion was then compared with any symptoms of recurrent stroke to see 
whether the MRI lesion corresponded with the symptoms.
Statistical Analysis
We compared nonparametric continuous variables using the Mann–
Whitney U test, and dichotomous variables using Fisher exact test. 
We created 2 further variables: any potential embolic source, mean-
ing the presence of either atrial fibrillation or symptomatic carotid 
stenosis (>50%) and any large-vessel disease, meaning the presence 
of ischemic heart disease, peripheral vascular disease, or carotid ste-
nosis on either side. We used binary logistic regression to perform 
a multivariate analysis, selecting variables based on our hypothesis 
and those that were statistically significant in the univariate analy-
sis. We analyzed the data using R Version 2.15.2 (R Foundation for 
Statistical Computing, Vienna, Austria; ISBN 3-900051-07-0; http://
www.R-project.org/).
Systematic Review
We referred to the recent systematic review of DWI in patients with 
both TIA and minor stroke11 and identified those studies that had pro-
vided data for nondisabling stroke separately from TIA. We updated 
the search that identified prospective studies of MRI in nondisabling 
minor stroke or TIA, to identify articles published up to October 2014. 
We included articles that provided data on mild stroke patients who 
underwent MRI and excluded retrospective case note reviews. We 
extracted data on study setting, inclusion/exclusion criteria, median 
National Institutes of Health Stroke Scale, delay between symptom 
onset and scan, imaging details, and number of participants with and 
without a lesion. We performed a meta-analysis of the proportion of 
patients with a DWI-negative stroke with a random-effects model us-
ing Stats Direct version 2.7.9 (StatsDirect statistical software; http://
www.statsdirect.com; StatsDirect Ltd, England, 2013), both with and 
without the data from our study.
Results
Participant Recruitment
During the study period (May 2010 to April 2012), 471 
patients were referred as potentially suitable for the study, of 
whom 264 were recruited (Figure 1), with final expert panel 
confirmed stroke. At 1-year post index stroke, 197 participants 
had in-person clinical and MRI follow-up, 151 had cognitive 
testing, and the remainder were followed up by post or by tele-
phone. No patients were lost to follow-up.
Main Findings
Of the 264 who had a final diagnosis of index stroke, 76 (29% 
of patients; 95% confidence interval, 23%–34%) had no acute 
ischemic MRI lesion. Most of the 188 acute ischemic lesions 
were seen on DWI (178 patients) and 10 of 264 patients had 
relevant acute lesions on T2/fluid-attenuated inversion recov-
ery only. Women and participants with a previous stroke or 
TIA were more likely to have no acute ischemic lesion on MRI 
(Table 1). Participants without an MRI lesion had a similar 
profile of vascular risk factors (diabetes mellitus, hypertension, 
high cholesterol, or smoking), noncarotid large-vessel arthero-
matous disease (peripheral vascular disease or ischemic heart 
disease), and were of a similar age to those with an acute isch-
emic lesion on MRI. DWI-positive patients were more likely 
to have carotid stenosis, atrial fibrillation, higher National 
Institutes of Health Stroke Scale, more WMH, and cortical 
stroke. DWI-negative patients were more likely to have isch-
emic heart disease or a previous stroke and be scanned later. 
After adjustment for age and sex, any embolic source and time 
to scanning were no longer associated with lesion presence.
At 1 year, 198 were scanned: 25 were too unwell, 35 
declined a further scan, and 3 were deceased. Of the 198 with a 
1-year scan, the patients without an acute ischemic index MRI 
lesion were just as likely to have persistent symptoms, cogni-
tive impairment, or recurrent stroke/TIA (Table 1) as those 
who had a DWI-positive index lesion. In addition, participants 
with an index lesion on DWI-MRI were more likely to have a 
new lesion (symptomatic or asymptomatic) on 1-year follow-
up MRI (20/147; 14%) than patients who had not had an index 
ischemic MRI lesion (1/50 2%; P=0.02; Table 2). If silent and 
symptomatic lesions at 1-year follow-up are considered sepa-
rately, both were more common in DWI-positive patients, but 
neither were statistically significant: 7 of 147, 5% of DWI-
positive patients had a symptomatic lesion and 13/147, 9% 
had a silent lesion; by contrast, no DWI-negative patients had 
a symptomatic lesion on 1-year follow-up and just 1 of 50 
(2%) had a silent lesion
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At 1 year post stroke, 4 patients with no index lesion had 
further events that had led to the original diagnosis of stroke 
being questioned: of these, 2 were thought to have epilepsy, 
1 may have had functional symptoms, and 1 may have had 
dementia. One patient who had a DWI-MRI index lesion and 
clinical features of stroke contacted us at 3 years post stroke 
(ie, 2 years after the last follow-up) to inform us that that 
patient had since been diagnosed with multiple sclerosis.
Table 2. Clinical and Imaging Recurrence of Stroke in Patients With and Without a Lesion Who Attended 
for 1-Year Follow-Up MRI
Events in the 1 y Follow-Up Period
Patients With an Index 
Stroke Lesion 
Patients Without an Index 
Stroke Lesion P Value
n=188 n=76
Recurrent stroke or TIA 19/188 (10%) 11/76 (14%) 0.39
Sub-set of 198 patients who had an MRI at 1 y post stroke
n=147 n=50
Any new lesion on MRI (with or without clinical features 
of stroke) patient had clinical features of stroke/TIA
20 (14%) 1 (2%) 0.018
New symptomatic lesion 7 (5%) 0 (0%) 0.19
New silent lesion 13 (9%) 1 (2%) 0.12
Recurrent stroke or TIA, but no new lesion 7 (5%) 7 (14%) 0.0496
No new clinical features of stroke/TIA in follow-up and no 
lesion on 1 y MRI
120 (82%) 42 (84%) 0.83
MRI indicates magnetic resonance imaging; and TIA, transient ischemic attack.
Figure 1. Recruitment into the study. MRI indicates 
magnetic resonance imaging; and TIA, transient 
ischemic attack.
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Systematic Review
Identification of Articles
We included 6 previous studies3,4,12–15 of 712 participants plus 
the present study, total sample of 976 participants (Table 3).
Study Characteristics
The studies used different definitions of nondisabling stroke: 
Schulz et al3 (n=164) included patients not requiring hospital 
admission; Winbeck et al15 (n=37) and Urra et al14 (n=208) 
included patients with National Institutes of Health Stroke 
Scale score of ≤5; Marx et al13 (n=19) only included patients 
with brain stem ischemia whose symptoms resolved com-
pletely within 1 week; Kastrup et al12 (n=37) only included 
patients referred for a carotid endarterectomy; and Doubal et 
al4 (n=253) (also performed in Edinburgh) used the same defi-
nition as the present study.
Meta-Analysis
Including the present study, the pooled estimate of the propor-
tion of patients with DWI-negative nondisabling stroke was 
21% (95% confidence interval, 12%–32%; Figure 2), with 
significant heterogeneity (I2; 93.3%). Excluding our study, the 
pooled proportion was 27% (95% confidence interval, 24%–
30%), indicating that our findings are consistent with the other 
studies.
Discussion
We found that nearly one third of patients with a nondisabling 
stroke have no visible acute ischemic lesion on DWI-MRI. 
One year later, they were just as likely to have recurrent stroke, 
cognitive impairment (Addenbrooke Cognitive Assessment 
Revised <88), or stroke-related disability (modified Rankin 
Scale score ≥2) as the patients with an acute index lesion. The 
only difference was that DWI-positive index stroke patients 
were more likely to have a new lesion on MRI at 1 year 
(symptomatic or asymptomatic) than the DWI-negative index 
stroke patients.
Of the studies identified in our review, ours is the largest, 
and the only one to follow-up all patients at 1 year with repeat 
MRI for those able to attend. The patients’ diagnoses were all 
assessed by a panel of stroke experts with access to all clinical 
information and investigations, and we only included patients 
for whom the panel was unable to find a more likely explana-
tion for the symptoms and signs than stroke. We followed up 
all patients at 1 year and carefully sought alternative diagno-
ses. It remains possible that some of the participants without 
an acute index lesion may have had a stroke mimic, such as 
migraine. But one might expect patients presenting with a 
stroke mimic to experience further events that would clarify 
the diagnosis, but in 95% of the DWI-negative patients, no 
other diagnosis has been made and several represented with 
recurrent stroke (including one who was given thrombolytic 
treatment).
Although it was the largest study on this topic to date, 
the sample is limited for a common disease like stroke. We 
scanned patients on the day of presentation to stroke special-
ists, but for some this may have been too late; our findings 
may not be applicable to a population where all are assessed 
immediately at symptom onset. However, our cohort repre-
sents a typical population of patients presenting with stroke 
and is consistent with other studies. Repeated scanning might 
identify some additional lesions, but this would be impractical 
and not representative of routine clinical practice. Although 
no patients were lost to follow-up, 25% were not able to have 
repeat MRI scanning at 1 year.
Our findings are consistent with the 6 other studies iden-
tified in our systematic review (n=718, n=978 including our 
study). Our finding that 11% of subjects without an index 
MRI lesion had a recurrent stroke in the first year is similar to 
the findings by Fujimoto et al16 who found that 7.8% of 102 
subjects without a DWI lesion had a recurrent stroke in the 
first 3 months (only published in abstract at present so not in 
our review). A retrospective study of a stroke unit population 
with more severe stroke17 found a much smaller proportion 
Table 3. Characteristics of Studies Included in Systematic Review
Setting and Population
Definition of  
Nondisabling Stroke Median NIHSS
Median Time Onset-Scan 
(Range or IQR) n
Number DWI 
Negative Ant/Post
Urra et al14 Consecutive patients with 
nondisabling stroke admitted 
to a stroke unit in Barcelona, 
Spain
NIHSS<5, premorbid modified 
Rankin Scale score <2, no 
contraindication to tPA
Thrombolyzed (n=119) 
3 (IQR, 2–4)
Not thrombolysed 
(n=84) 2 (IQR, 1–3.75)
Between day 2 and day 5. 203 62 (31%) Included
Winbeck et al15 Stroke Unit, at Department of 
Neurology, Germany
NIHSS <5 3.3 (mean) (0–5) Within 24 h 37 0 Anterior
Marx et al13 Neurology Department, 
Germany
Lasted no >1 wk and 
resolved completely
Not reported Within 24 h of onset of 
symptoms
19 10 (53%) Brain stem 
only.
Kastrup et al12 Patients admitted to hospital 
for an carotid endarterectomy; 
all had a carotid stenosis >70%
Fit for carotid endarterectomy Not reported Within 14 d 36 0 Anterior
Schulz et al3 Referred to an outpatient TIA 
and nondisabling stroke clinic 
>3 d after the event
Well enough to remain at 
home and not need inpatient 
admission.
1 (0–9) 17 (IQR, 10-22) 164 50 (30%) Both
Doubal et al4 Inpatients and outpatients: 
Lothian
Lacunar stroke, and partial 
anterior circulation stroke. 
Inpatient and outpatient
2 (0–8) 12 (IQR, 4–27) d 253 81 (32%) Anterior
DWI indicates diffusion-weighted imaging; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; TIA, transient ischemic attack; and tPA, tissue-
type plasminogen activator.
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of stroke patients without a lesion on DWI-MRI (16/701) 
although retrospective studies are prone to bias.
Why did some patients not have a DWI-MRI lesion? 
Perhaps the diagnosis was wrong; however, no DWI-negative 
patients were proven to have a nonvascular cause of their 
symptoms on either a subsequent scan or autopsy. DWI-MRI 
may also have false positives because DWI is not specific for 
ischemia.18 Four patients had some evidence that their index 
event could possibly have been a stroke mimic because they 
had further events that led to the original diagnosis being ques-
tioned although no alternative was proven. However, in gen-
eral, patients with mimics such as migraine or seizures should 
not be disabled or cognitively impaired at 1 year, and 42% of 
DWI-negative patients had a modified Rankin Scale score ≥2 
at 1 year, similar to those with a DWI-positive index lesion. 
The excess of previous vascular disease in patients without an 
index acute lesion on MRI suggests that these patients may be 
more aware of the need to seek medical attention for any new 
neurological symptoms.
DWI is sensitive to acute ischemia. The increased signal 
that makes the ischemic tissue visible is because of restricted 
water diffusion in the extracellular space as water shifts from 
the extra- to the intracellular space (intracellular edema) in 
early ischemia. However, consideration of the pathophysi-
ological changes that lead to cellular edema shows that the 
reduction in cerebral blood flow required to initiate cell swell-
ing is more severe than that required to produce acute neu-
rological symptoms (Figure 3).19 Additionally, the chance of 
seeing an acute ischemic lesion on DWI-MRI increases as 
the severity of the stroke increases and with the duration of 
ischemia.20 Data from highly standardized experimental large 
artery stroke models demonstrate variability in infarct extent 
on DWI and a close relationship between depth and duration 
of the perfusion reduction and DWI visibility,21 but there are 
no data (to our knowledge) on DWI appearances in experi-
mental minor stroke. Therefore, it is possible that some small 
(nondisabling) strokes reflect a reduction in blood flow severe 
enough to cause symptoms, but not severe enough to cause a 
DWI lesion, or that the DWI lesion was transient, was missed 
by scanning, and did not show up on structural MR sequences 
either (these are known to be less sensitive to small infarcts).22
It is intriguing that there were more recurrent infarcts, 
including silent infarcts, visible on the 1-year follow-up MRI 
in the patients with a visible index DWI-MRI lesion than in 
those without. This might suggest some differential vulnera-
bility to developing infarction, which might be consistent with 
there being more WMH in the patients with DWI-positive 
index lesions than in those with DWI-negative lesions; WMH 
are associated with more infarct growth after hyperacute 
stroke,23 which has been interpreted as greater susceptibility 
to ischemia. Alternatively, the excess of previous vascular dis-
ease in patients without an index acute lesion on MRI suggests 
that these patients may be more aware of the need to seek 
medical attention for any new neurological symptoms.
Additional studies should include long-term follow-up 
to determine why some patients with no other explanation 
for their neurological symptoms apart from stroke do not to 
Figure 2. Forest plot of the pooled pro-
portion of subjects with nondisabling 
stroke without a lesion on magnetic 
resonance imaging with diffusion weight-
ing: median National Institutes of Health 
Stroke Scale <5 in all studies.
Figure 3. Relationship between symptoms, cerebral blood flow 
(CBF) and diffusion-weighted imaging (DWI) lesion.
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develop a visible lesion on DWI yet have similar cognitive and 
physical outcomes to those with a DWI lesion. Similar patients 
must have been included in secondary prevention studies, 
many of which were performed before widespread DWI avail-
ability or did not use DWI positivity as an entry requirement. 
Meantime patients with a clinical diagnosis of stroke who are 
DWI-negative have the same high risk of recurrent stroke and 
disability as DWI-positive patients and should receive second-
ary stroke prevention until further evidence on their specific 
management is available.
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